Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06444815
Title A Study of VET3-TGI in Patients With Solid Tumors (STEALTH-001)
Acronym STEALTH-001
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors KaliVir Immunotherapeutics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.